NUVB
Nuvation Bio Inc
NYSE · Pharmaceuticals
$5.70
+0.08 (+1.42%)
Open$5.82
Previous Close$5.62
Day High$6.15
Day Low$5.68
52W High$9.75
52W Low$1.54
Volume—
Avg Volume5.13M
Market Cap1.96B
P/E Ratio—
EPS$-0.64
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+658.2% upside
Current
$5.70
$5.70
Target
$43.22
$43.22
$30.63
$43.22 avg
$69.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 10.07M | 781.90M | 798.00M |
| Net Income | -726,554,439 | 141.36M | 136.11M |
| Profit Margin | -7,213.8% | 18.1% | 17.1% |
| EBITDA | -759,837,515 | 195.91M | 227.47M |
| Free Cash Flow | — | 85.45M | 83.04M |
| Rev Growth | — | +23.6% | -6.7% |
| Debt/Equity | 0.01 | 0.84 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |